Patrick Fisher, President of Global Limb Recon at Orthofix Medical Inc. (NASDAQ:OFIX), filed a Form 4 on September 3, 2026, disclosing the sale of 150 shares of common stock on September 1, 2026.
Key Highlights
- Shares Sold: 150 shares of Orthofix Medical common stock were disposed of on September 1, 2026.
- Sale Price: The shares were sold at $9.39 per share.
- 10b5-1 Plan: The sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2026.
- Remaining Ownership: Following the transaction, Fisher beneficially owned 51,069 shares directly, including 36,028 previously reported restricted stock units.
- Reporting Person: Patrick Fisher holds the title of President, Global Limb Recon at Orthofix Medical Inc.
Patrick Fisher Disposes of Orthofix Common Stock Via Pre-Set Trading Plan
According to the filing, Patrick Fisher, an officer of Orthofix Medical Inc. identified as President, Global Limb Recon, sold 150 shares of the company's common stock on September 1, 2026, at a price of $9.39 per share. The transaction was coded "S," indicating an open-market sale, and was reported as a direct disposition. The filing notes the transaction was carried out under a Rule 10b5-1 trading plan that Fisher adopted on May 29, 2026.
Following the reported sale, Fisher's total direct beneficial ownership stood at 51,069 shares, according to the filing. The filing further discloses that this figure includes 36,028 previously reported restricted stock units. No derivative securities transactions were reported in Table II of the filing.
The Form 4 was signed by J. Andres Cedron as attorney-in-fact on behalf of Fisher and was filed on September 3, 2026. The filing was submitted pursuant to Section 16(a) of the Securities Exchange Act of 1934, and the box indicating a Rule 10b5-1(c) compliant transaction was checked on the cover page of the form.
What Was Disclosed
Patrick Fisher, President of Global Limb Recon at Orthofix Medical Inc., disclosed a sale of 150 shares of common stock at $9.39 per share on September 1, 2026, executed under a pre-established 10b5-1 trading plan, leaving him with 51,069 shares beneficially owned directly.



Please wait processing your request...